APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1

ABSTRACT Humans encode proteins, called restriction factors, that inhibit replication of viruses such as HIV-1. The members of one family of antiviral proteins, apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3; shortened here to A3), act by deaminating cytidines to uridines...

Full description

Bibliographic Details
Main Authors: Mollie M. McDonnell, Kate H. D. Crawford, Adam S. Dingens, Jesse D. Bloom, Michael Emerman
Format: Article
Language:English
Published: American Society for Microbiology 2020-04-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mBio.00737-20
_version_ 1818995550453760000
author Mollie M. McDonnell
Kate H. D. Crawford
Adam S. Dingens
Jesse D. Bloom
Michael Emerman
author_facet Mollie M. McDonnell
Kate H. D. Crawford
Adam S. Dingens
Jesse D. Bloom
Michael Emerman
author_sort Mollie M. McDonnell
collection DOAJ
description ABSTRACT Humans encode proteins, called restriction factors, that inhibit replication of viruses such as HIV-1. The members of one family of antiviral proteins, apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3; shortened here to A3), act by deaminating cytidines to uridines during the reverse transcription reaction of HIV-1. The A3 locus encodes seven genes, named A3A to A3H. These genes have either one or two cytidine deaminase domains, and several of these A3s potently restrict HIV-1. A3C, which has only a single cytidine deaminase domain, however, inhibits HIV-1 only very weakly. We tested novel double domain protein combinations by genetically linking two A3C genes to make a synthetic tandem domain protein. This protein created a “super restriction factor” that had more potent antiviral activity than the native A3C protein, which correlated with increased packaging into virions. Furthermore, disabling one of the active sites of the synthetic tandem domain protein resulted in an even greater increase in the antiviral activity—recapitulating a similar evolution seen in A3F and A3G (double domain A3s that use only a single catalytically active deaminase domain). These A3C tandem domain proteins do not have an increase in mutational activity but instead inhibit formation of reverse transcription products, which correlates with their ability to form large higher-order complexes in cells. Finally, the A3C-A3C super restriction factor largely escaped antagonism by the HIV-1 viral protein Vif. IMPORTANCE As a part of the innate immune system, humans encode proteins that inhibit viruses such as HIV-1. These broadly acting antiviral proteins do not protect humans from viral infections because viruses encode proteins that antagonize the host antiviral proteins to evade the innate immune system. One such example of a host antiviral protein is APOBEC3C (A3C), which weakly inhibits HIV-1. Here, we show that we can improve the antiviral activity of A3C by duplicating the DNA sequence to create a synthetic tandem domain and, furthermore, that the proteins thus generated are relatively resistant to the viral antagonist Vif. Together, these data give insights about how nature has evolved a defense against viral pathogens such as HIV.
first_indexed 2024-12-20T21:15:38Z
format Article
id doaj.art-f1374489112c4b6484f89a474867ce79
institution Directory Open Access Journal
issn 2150-7511
language English
last_indexed 2024-12-20T21:15:38Z
publishDate 2020-04-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj.art-f1374489112c4b6484f89a474867ce792022-12-21T19:26:26ZengAmerican Society for MicrobiologymBio2150-75112020-04-0111210.1128/mBio.00737-20APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1Mollie M. McDonnell0Kate H. D. Crawford1Adam S. Dingens2Jesse D. Bloom3Michael Emerman4Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, USADivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USADivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USADivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USADivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAABSTRACT Humans encode proteins, called restriction factors, that inhibit replication of viruses such as HIV-1. The members of one family of antiviral proteins, apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3; shortened here to A3), act by deaminating cytidines to uridines during the reverse transcription reaction of HIV-1. The A3 locus encodes seven genes, named A3A to A3H. These genes have either one or two cytidine deaminase domains, and several of these A3s potently restrict HIV-1. A3C, which has only a single cytidine deaminase domain, however, inhibits HIV-1 only very weakly. We tested novel double domain protein combinations by genetically linking two A3C genes to make a synthetic tandem domain protein. This protein created a “super restriction factor” that had more potent antiviral activity than the native A3C protein, which correlated with increased packaging into virions. Furthermore, disabling one of the active sites of the synthetic tandem domain protein resulted in an even greater increase in the antiviral activity—recapitulating a similar evolution seen in A3F and A3G (double domain A3s that use only a single catalytically active deaminase domain). These A3C tandem domain proteins do not have an increase in mutational activity but instead inhibit formation of reverse transcription products, which correlates with their ability to form large higher-order complexes in cells. Finally, the A3C-A3C super restriction factor largely escaped antagonism by the HIV-1 viral protein Vif. IMPORTANCE As a part of the innate immune system, humans encode proteins that inhibit viruses such as HIV-1. These broadly acting antiviral proteins do not protect humans from viral infections because viruses encode proteins that antagonize the host antiviral proteins to evade the innate immune system. One such example of a host antiviral protein is APOBEC3C (A3C), which weakly inhibits HIV-1. Here, we show that we can improve the antiviral activity of A3C by duplicating the DNA sequence to create a synthetic tandem domain and, furthermore, that the proteins thus generated are relatively resistant to the viral antagonist Vif. Together, these data give insights about how nature has evolved a defense against viral pathogens such as HIV.https://journals.asm.org/doi/10.1128/mBio.00737-20APOBEC3CHIV-1restriction factorVifinnate immunity
spellingShingle Mollie M. McDonnell
Kate H. D. Crawford
Adam S. Dingens
Jesse D. Bloom
Michael Emerman
APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1
mBio
APOBEC3C
HIV-1
restriction factor
Vif
innate immunity
title APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1
title_full APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1
title_fullStr APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1
title_full_unstemmed APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1
title_short APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1
title_sort apobec3c tandem domain proteins create super restriction factors against hiv 1
topic APOBEC3C
HIV-1
restriction factor
Vif
innate immunity
url https://journals.asm.org/doi/10.1128/mBio.00737-20
work_keys_str_mv AT molliemmcdonnell apobec3ctandemdomainproteinscreatesuperrestrictionfactorsagainsthiv1
AT katehdcrawford apobec3ctandemdomainproteinscreatesuperrestrictionfactorsagainsthiv1
AT adamsdingens apobec3ctandemdomainproteinscreatesuperrestrictionfactorsagainsthiv1
AT jessedbloom apobec3ctandemdomainproteinscreatesuperrestrictionfactorsagainsthiv1
AT michaelemerman apobec3ctandemdomainproteinscreatesuperrestrictionfactorsagainsthiv1